Abstract
Mitochondria are important targets for cancer chemotherapy and other disease treatments. Gaining access to this organelle can be difficult, as the inner membrane is a barrier limiting diffusive transport. A mitochondrial molecular carrier would be a boon to the development of organelle-specific therapeutics. Here, we report a significant advance in the development of mitochondrial transporters-synthetic cell-permeable peptides that are able to enter mitochondria. Efficient uptake of these mitochondria-penetrating peptides (MPPs) is observed in a variety of cell types, and organellar specificity is attained with sequences that possess specific chemical properties. The MPPs identified are cationic, but also lipophilic; this combination of characteristics facilitates permeation of the hydrophobic mitochondrial membrane. The examination of a panel of MPPs illustrates that mitochondrial localization can be rationally controlled and finely tuned by altering lipophilicity and charge.
Original language | English (US) |
---|---|
Pages (from-to) | 375-382 |
Number of pages | 8 |
Journal | Chemistry and Biology |
Volume | 15 |
Issue number | 4 |
DOIs | |
State | Published - Apr 21 2008 |
Externally published | Yes |
Funding
We thank the NSF (CAREER award to S.O.K.) and the University of Toronto for their support of this work. We also acknowledge James Jonkman and the Advanced Optical Microscopy Facility at Princess Margaret Hospital for expert assistance with confocal fluorescence imaging.
Keywords
- CHEMBIO
ASJC Scopus subject areas
- Drug Discovery
- Molecular Medicine
- Molecular Biology
- Biochemistry
- Clinical Biochemistry
- Pharmacology